Hunan Celis Biotech
Changsha, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A Chinese biotech firm developing innovative biologic drugs for cancer treatment.
Oncology
Technology Platform
Platform for engineering therapeutic antibodies and other protein-based biologics targeting oncology pathways.
Opportunities
Potential to be acquired or form lucrative partnerships with larger pharma companies if its clinical data demonstrates best-in-class potential.
Risk Factors
High risk of clinical failure or inability to differentiate its candidates in a crowded field of similar biologic therapies.
Competitive Landscape
Operates in the intensely competitive Chinese oncology biologics space, with many companies pursuing similar antibody-based mechanisms.